|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Loss for the year | ||||
| Adjustments to reconcile loss to net cash used in operating activities: | ||||
| Depreciation | ||||
| Share-based payment | ||||
| Exchange rate changes on cash and cash equivalents | ||||
| Revaluation of derivatives and warrants liabilities | ||||
| Changes in operating assets and liabilities: | ||||
| Decrease (increase) in accounts receivable | ||||
| Decrease (increase) in other current assets | ||||
| Increase in inventory | ||||
| Change in operating lease liability, net. | ||||
| Increase (decrease) in trade accounts payable | ||||
| Increase (decrease) in other accounts payable | ||||
| Net cash used in operating activities | ||||
| Purchase of fixed assets | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Proceeds from a convertible loan credit facility and issuance of warrants | ||||
| Payments on convertible loan credit facility | ||||
| Proceeds from exercise of warrants, net of issuance expenses | ||||
| Net cash provided by financing activities | ||||
| Effect of exchange rate changes on cash and cash equivalents | ||||
| Increase (decrease) in cash, cash equivalents and restricted cash | ||||
| Cash, cash equivalents and restricted cash at the beginning of the period | ||||
| Cash, cash equivalents and restricted cash at the end of the period | ||||
| Non-Cash Activities: | ||||
| Conversion of a convertible loan credit facility to ordinary shares | ||||
| Issuance expenses recorded in other accounts payables | ||||
Loading...
